Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 732-749
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.732
Table 6 Univariate and multivariate Cox regression analysis for disease-free survival in gastric cancer patients
Variables

Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Age in yr1.0261.009-1.0430.003a1.0050.988-1.0220.589
Tumor dimensions in cm< 3/≥ 32.6791.772-4.051< 0.001a1.1650.736-1.8440.514
DifferentiationModerate and poor/well0.2410.060-0.9740.046a0.6740.48-3.0560.609
Her-2Negative/positive2.1510.247-1.1230.0970.5630.258-1.2290.149
TNM stage< 0.001a< 0.001a
IRefRef
II2.9201.546-5.5120.001a1.7260.774-3.8500.182
III5.1672.844-9.387< 0.001a4.0711.757-9.4350.001a
Operation time in min1.0031.001-1.0050.014a1.0020.999-1.0040.201
Perioperative transfusionNo/yes2.2881.666-3.141< 0.001a1.3770.954-1.9890.088
CA199 in ng/mLNegative/positive1.8521.292-2.6530.001a1.2510.851-1.8380.255
CEA in ng/mLNegative/positive1.7801.280-2.4760.001a1.2340.875-1.7410.231
Lymph node metastasis rate, %0.9980.988-1.0080.6980.9930.982-1.0050.238
Postoperative complicationNo or minor/major3.9802.895-5.470< 0.001a1.6041.115-2.3070.011a
Postoperative chemotherapyNo/yes1.8361.248-2.7020.002a0.6090.365-1.0180.059
Lymphocytes as × 109/L0.5150.378-0.703< 0.001a0.9540.669-1.3590.792
Neutrophils as × 109/L1.1921.119-1.269< 0.001a1.0360.938-1.1440.484
Monocyte as × 109/L5.9462.457-14.387< 0.001a0.9800.301-3.1880.973
Albumin in g/L0.8840.857-0.912< 0.001a0.9590.920-0.9990.044a
Fibrinogen in g/L2.1411.867-2.456< 0.001a1.4071.126-1.7590.003a
SIRI1.1421.080-1.207< 0.001a1.0760.913-1.2680.380
AFR0.7350.692-0.780< 0.001a0.9310.700-1.2390.625
SIRI-AFR score< 0.001a
0RefRef
16.0423.339-10.931< 0.001a3.5431.844-6.809< 0.001a
218.20710.138-32.699< 0.001a5.0052.256-11.107< 0.001a